---
schema_version: "secwatch.filing_event.v1"
accession: "0001493712-25-000005"
form_type: "8-K"
ticker: "STME"
cik: "0001493712"
company_name: "Stimcell Energetics Inc."
filed_at: "2025-12-02T23:59:59+00:00"
generated_at: "2026-05-16T15:41:17.155789+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# StimCell signs research agreement with St. Boniface Hospital to study eBalance on mitochondrial function

## Summary
- Service agreement with St. Boniface Hospital Albrechtsen Research Centre, effective Dec 1, 2025.
- Study will examine eBalance® microcurrent device effects on mitochondrial function in sensory neurons.
- Principal Investigator Prof. Paul Fernyhough; project expected to last approximately three months.
- Measurements include oxygen consumption rates, ATP production, glycolysis, and enzyme activities.

## SEC filing metadata
- accession: 0001493712-25-000005
- form_type: 8-K
- ticker: STME
- cik: 0001493712
- company_name: Stimcell Energetics Inc.
- filed_at: 2025-12-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493712/000149371225000005/0001493712-25-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493712/000149371225000005/stme-20251202_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493712-25-000005
- JSON: https://secwatch.observer/filing/0001493712-25-000005.json
- Plain text: https://secwatch.observer/filing/0001493712-25-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.